ATAC Summary The ATAC Completed Treatment Analysis extends and strengthens the evidence that 5 years of anastrozol is significantly more effective and better tolerated than 5 years of tamoxifen The overall risk:benefit profile remains clearly in favour of anastrozol The absolute benefits for anastrozol over and above those of tamoxifen continue to increase with time and extend beyond the completion of therapy
{}